Second Syndrome
PrivateLast Round
Strategic
Dec 1, 2022
Total Funding Raised
$14.67M
Company Overview
Second Syndrome operates in Real Estate & PropTech and is based in Seoul. Its latest recorded funding round was a Strategic round in December 2022.
Second Syndrome is a South Korean infrastructure technology company that operates 'DaLock', a leading app-based self-storage and managed warehousing service.
Sector
Real Estate & PropTech
Verticals
Property Management, Facility Management, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Second Syndrome Comparables
Compare Second Syndrome with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QubizKorea Co., Ltd. | 89% | |
| Boxful Korea | 88% | |
| IAMBOX Korea | 87% |
For institutional investors. Book with your work email.
Second Syndrome Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 1, 2022 | ||||
| Series B | Jan 1, 2021 | ||||
| Series A | Sep 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Second Syndrome Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kakao Ventures | Series A, Series B |
| Wonik Investment Partners | Series B |
| Korea Omega Investment Corp | Series B |
| Daol Investment | Series B |
| Quantum Ventures Korea | Series B |
| SBI Investment Co., Ltd. | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 41% MoM.
- Mar 2, 2026
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Second Syndrome Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Second Syndrome's valuation, stock price, and market status.
Is Second Syndrome a public or private company?
Second Syndrome is a private company.
What is the current stock price of Second Syndrome?
Second Syndrome is a private company, so its shares have no public market price. Caplight tracks Second Syndrome's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Second Syndrome worth (valuation)?
Valuation information for Second Syndrome is not publicly available.
Can I buy Second Syndrome stock?
Second Syndrome shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Second Syndrome's last funding round?
Second Syndrome's most recent funding round was Strategic on December 1, 2022.
Who are the main investors in Second Syndrome?
Key investors in Second Syndrome include Daol Investment.
Will Second Syndrome IPO soon?
No public IPO plans have been announced for Second Syndrome.
How can I track Second Syndrome secondary market activity?
Caplight tracks bids, offers, and trades in Second Syndrome's shares on secondary markets.